AngioDynamics Inc. (ANGO) Financial Statements (2025 and earlier)
Company Profile
| Business Address |
14 PLAZA DRIVE LATHAM, NY 12110 |
| State of Incorp. | DE |
| Fiscal Year End | May 31 |
| Industry (SIC) | 3841 - Surgical and Medical Instruments and Apparatus (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)Annual | Quarterly
| 2/28/2025 Q3 | 11/30/2024 Q2 | 8/31/2024 Q1 | 5/31/2024 Q4 | 2/29/2024 Q3 | 11/30/2023 Q2 | 8/31/2023 Q1 | |||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Cash, cash equivalents, and short-term investments | 54,089 | 55,005 | 76,056 | 78,451 | 60,896 | 57,586 | |||
| Cash and cash equivalent | 54,089 | 55,005 | 76,056 | 78,451 | 60,896 | 57,586 | |||
| Receivables | 43,158 | 39,563 | 43,610 | 49,475 | 51,603 | 49,755 | |||
| Inventory, net of allowances, customer advances and progress billings | 65,918 | 64,700 | 60,616 | 58,068 | 64,254 | 59,972 | |||
| Inventory | 65,918 | 64,700 | 60,616 | 58,068 | 64,254 | 59,972 | |||
| Prepaid expense | 2,762 | ||||||||
| Business combination, contingent consideration, asset | |||||||||
| Other undisclosed current assets | 12,195 | 13,326 | 10,209 | 10,913 | 8,715 | 8,162 | |||
| Total current assets: | 175,360 | 172,594 | 193,253 | 196,907 | 185,468 | 175,475 | |||
| Noncurrent Assets | |||||||||
| Property, plant and equipment | 32,977 | 34,377 | 35,666 | 37,040 | 42,557 | 43,356 | |||
| Intangible assets, net (including goodwill) | 73,110 | 75,774 | 77,383 | 81,570 | 263,117 | 265,688 | |||
| Goodwill | 159,226 | 159,017 | |||||||
| Intangible assets, net (excluding goodwill) | 73,110 | 75,774 | 77,383 | 81,570 | 103,891 | 106,671 | |||
| Other noncurrent assets | 10,103 | 10,883 | 11,369 | 9,325 | 8,481 | 9,430 | |||
| Total noncurrent assets: | 116,190 | 121,034 | 124,418 | 127,935 | 314,155 | 318,474 | |||
| TOTAL ASSETS: | 291,550 | 293,628 | 317,671 | 324,842 | 499,623 | 493,949 | |||
| LIABILITIES AND EQUITY | |||||||||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts payable and accrued liabilities | 74,665 | 65,380 | 78,849 | 66,115 | 66,887 | 50,886 | |||
| Accounts payable | 34,746 | 31,272 | 37,751 | 35,152 | 37,650 | 24,807 | |||
| Accrued liabilities | 39,919 | 34,108 | 41,098 | 30,963 | 29,237 | 26,079 | |||
| Business combination, contingent consideration, liability | 4,960 | 4,804 | 4,728 | 9,500 | 9,387 | 4,729 | |||
| Other liabilities | 8,970 | 6,515 | 7,578 | 10,259 | 1,763 | 1,837 | |||
| Total current liabilities: | 88,595 | 76,699 | 91,155 | 85,874 | 78,037 | 57,452 | |||
| Noncurrent Liabilities | |||||||||
| Liabilities, other than long-term debt | 14,883 | 19,211 | 20,017 | 16,675 | 5,170 | 7,414 | |||
| Other liabilities | 11,853 | 15,721 | 16,078 | 14,353 | 2,602 | 2,976 | |||
| Operating lease, liability | 3,030 | 3,490 | 3,939 | 2,322 | 2,568 | ||||
| Business combination, contingent consideration, liability | 4,438 | ||||||||
| Other undisclosed noncurrent liabilities | 1,304 | 1,136 | 913 | 3,595 | 15,190 | 1,279 | |||
| Total noncurrent liabilities: | 16,187 | 20,347 | 20,930 | 20,270 | 20,360 | 8,693 | |||
| Total liabilities: | 104,782 | 97,046 | 112,085 | 106,144 | 98,397 | 66,145 | |||
| Equity | |||||||||
| Equity, attributable to parent | 186,768 | 196,582 | 205,586 | 218,698 | 401,226 | 427,804 | |||
| Common stock | 384 | 386 | 385 | 385 | 383 | 383 | |||
| Treasury stock, value | (7,381) | (6,265) | (5,714) | (5,714) | (5,714) | (5,714) | |||
| Additional paid in capital | 616,253 | 613,730 | 610,484 | 608,588 | 605,284 | 603,759 | |||
| Accumulated other comprehensive loss | (3,748) | (3,267) | (4,365) | (2,806) | (4,708) | (5,653) | |||
| Accumulated deficit | (418,740) | (408,002) | (395,204) | (381,755) | (194,019) | (164,971) | |||
| Total equity: | 186,768 | 196,582 | 205,586 | 218,698 | 401,226 | 427,804 | |||
| TOTAL LIABILITIES AND EQUITY: | 291,550 | 293,628 | 317,671 | 324,842 | 499,623 | 493,949 | |||
Income Statement (P&L) ($ in thousands)Annual | Quarterly
| 2/28/2025 Q3 | 11/30/2024 Q2 | 8/31/2024 Q1 | 5/31/2024 Q4 | 2/29/2024 Q3 | 11/30/2023 Q2 | 8/31/2023 Q1 | ||
|---|---|---|---|---|---|---|---|---|
| Revenues | 72,845 | 67,491 | 70,980 | 75,182 | 79,073 | 78,679 | ||
| Cost of revenue (Cost of Product and Service Sold) | (32,939) | (30,767) | (32,465) | (39,321) | (38,811) | (38,619) | ||
| Gross profit: | 39,906 | 36,724 | 38,515 | 35,861 | 40,262 | 40,060 | ||
| Operating expenses | (51,000) | (49,822) | (52,964) | (242,414) | (53,382) | (52,872) | ||
| Other undisclosed operating income | 6,657 | 47,842 | ||||||
| Operating income (loss): | (11,094) | (13,098) | (14,449) | (199,896) | (13,120) | 35,030 | ||
| Nonoperating income (expense) | 246 | 433 | (1,306) | 156 | 502 | (169) | ||
| Other nonoperating income (expense) | 12 | (173) | (238) | (32) | (288) | |||
| Interest and debt expense | 394 | 534 | 119 | |||||
| Income (loss) from continuing operations before equity method investments, income taxes: | (10,848) | (12,665) | (15,755) | (199,346) | (12,084) | 34,980 | ||
| Other undisclosed income (loss) from continuing operations before income taxes | 1,614 | (394) | (534) | (119) | ||||
| Income (loss) from continuing operations before income taxes: | (10,848) | (12,665) | (14,141) | (199,740) | (12,618) | 34,861 | ||
| Income tax expense (benefit) | 110 | (133) | 692 | 12,004 | (16,430) | 11,023 | ||
| Net income (loss) available to common stockholders, diluted: | (10,738) | (12,798) | (13,449) | (187,736) | (29,048) | 45,884 | ||
Comprehensive Income ($ in thousands)Annual | Quarterly
| 2/28/2025 Q3 | 11/30/2024 Q2 | 8/31/2024 Q1 | 5/31/2024 Q4 | 2/29/2024 Q3 | 11/30/2023 Q2 | 8/31/2023 Q1 | ||
|---|---|---|---|---|---|---|---|---|
| Net income (loss): | (10,738) | (12,798) | (13,449) | (187,736) | (29,048) | 45,884 | ||
| Other comprehensive income (loss) | (481) | 1,098 | (1,559) | 1,902 | 945 | (930) | ||
| Comprehensive income (loss), net of tax, attributable to parent: | (11,219) | (11,700) | (15,008) | (185,834) | (28,103) | 44,954 | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.